NCT00132210 - Pegylated Interferon Therapy for Acute Hepatitis C Infection in HIV-infected Patients | Biotech Hunter

Enrollment

200

Participants

Timeline

Start Date

September 30, 2002

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions

Hepatitis CHIV Infections

Interventions

DRUG

pegylated interferon

Pegylated interferon alfa-2a or -2b in standard dosage Ribavirin in case of genotype 1 or 4 at 1000 or 1200 mg/d according to body weight ist recommended.

Trial Locations (14)

10117

Practice Hintsche, Berlin

10243

Practice Bieniek, Berlin

10439

Practice Dupke/Carganico/Baumgarten, Berlin

10627

Practice Schranz, Berlin

10777

Practice Freiwald/Rausch, Berlin

Practice Jessen, Berlin

12047

Practice Kluschke, Berlin

13347

Ärzteforum Seestraße, Berlin

14057

Practice Center Kaiserdamm, Berlin

20099

Practice St. Georg, Hamburg

20146

Practice Fenske, Hamburg

20359

Practice Linnig, Hamburg

53127

Medical Department I, University Hospital, Bonn University, Bonn

70197

Practice Trein, Stuttgart

All Listed Sponsors

lead

University Hospital, Bonn

OTHER